Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Declines By 56.0%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) was the target of a large drop in short interest in the month of December. As of December 31st, there was short interest totalling 1,530,000 shares, a drop of 56.0% from the December 15th total of 3,480,000 shares. Based on an average daily trading volume, of 6,330,000 shares, the days-to-cover ratio is currently 0.2 days. Currently, 4.2% of the company’s shares are short sold.

Cardio Diagnostics Price Performance

CDIO stock traded down $0.05 during trading on Tuesday, reaching $0.58. The company had a trading volume of 601,689 shares, compared to its average volume of 1,485,239. The business has a 50 day moving average of $0.65 and a 200 day moving average of $0.46. Cardio Diagnostics has a 52 week low of $0.19 and a 52 week high of $2.83.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.